ResMed Inc (BSP:R1MD34)
R$ 381 9.84 (2.65%) Market Cap: 223.72 Bil Enterprise Value: 226.25 Bil PE Ratio: 32.98 PB Ratio: 7.04 GF Score: 86/100

Resmed Inc at Credit Suisse Healthcare Conference (Virtual) Transcript

Nov 10, 2021 / 06:00PM GMT
Release Date Price: R$352.1
Gretel Janu;dit Suisse AG
CrÃ;Research Division - Research Analyst

© -

Hello, everyone. So my name is Gretel Janu. I'm the Australian Healthcare Analyst. I am very pleased to have Mick Farrell, CEO of ResMed here with us today for a fireside chat. As we go through the fireside chat if you have any questions, please feel free to send them through to my email, that's [email protected] and I'll throw your questions into our conversation here today. So Nick, thank you so much for joining us today, and thanks for participating in our conference. It's definitely been a very exciting, interesting period for ResMed over the last 12 to 18 months with COVID recovery, supply chain challenges and now the Philips recall. So I guess to start off, do you want to mention how ResMed is responding at the moment to all of these different challenges. And how is ResMed's positioned to continue to grow strongly through the medium term and into longer term. Thank you.

Michael J. Farrell
ResMed Inc. - CEO & Director

Yes, Gretel, great opener.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot